Edgewise Therapeutics, Inc.
NASDAQ:EWTX
26.7 (USD) • At close December 31, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -100.163 | -67.64 | -42.813 | -17.123 | -9.705 |
| Depreciation & Amortization
| 1.732 | 0.538 | 0.272 | 0.185 | 0.123 |
| Deferred Income Tax
| 0 | 0 | -2.294 | -0.203 | -0.048 |
| Stock Based Compensation
| 17.56 | 10.924 | 4.404 | 0.354 | 0.077 |
| Change In Working Capital
| -1.56 | 4.086 | 4.63 | 1.95 | 0.334 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.092 | 0.047 | 2.654 | 0.521 | 0.275 |
| Other Working Capital
| -1.468 | 4.039 | 1.976 | 1.429 | 0.059 |
| Other Non Cash Items
| -9.517 | -0.543 | 2.294 | 0.203 | 0.048 |
| Operating Cash Flow
| -91.948 | -52.635 | -33.507 | -14.634 | -9.171 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -5.745 | -5.546 | -0.668 | -0.203 | -0.18 |
| Acquisitions Net
| 0 | 0.065 | 0.242 | 0 | 0 |
| Purchases Of Investments
| -255.866 | -292.388 | -288.203 | -24.178 | 0 |
| Sales Maturities Of Investments
| 364.497 | 227.357 | 46.644 | 0 | 0 |
| Other Investing Activites
| 0 | -0.065 | -0.242 | -0.024 | 0 |
| Investing Cash Flow
| 102.886 | -70.577 | -242.227 | -24.381 | -0.18 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 52.618 | 129.165 | 186.148 | 120.278 | 24.8 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 1.261 | 0.474 | 0.236 | 120.278 | 24.8 |
| Financing Cash Flow
| 53.166 | 129.639 | 186.384 | 120.278 | 24.8 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 64.104 | 6.427 | -89.35 | 81.263 | 15.449 |
| Cash At End Of Period
| 86.097 | 21.993 | 15.566 | 104.916 | 23.653 |